Zura Bio Ltd. Files 8-K with Financials and Exhibits
Ticker: ZURA · Form: 8-K · Filed: Jun 6, 2024 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
TL;DR
Zura Bio dropped an 8-K with financials and exhibits on 6/6/24. Check it out.
AI Summary
Zura Bio Ltd. announced on June 6, 2024, a Regulation FD Disclosure and the filing of Financial Statements and Exhibits. The company, formerly JATT Acquisition Corp, is incorporated in the Cayman Islands and operates in the biological products sector. Its principal executive offices are located in Henderson, Nevada.
Why It Matters
This filing provides crucial updates on Zura Bio Ltd.'s financial status and operational disclosures, which are important for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Zura Bio Ltd (company) — Registrant
- JATT Acquisition Corp (company) — Former Company Name
- June 6, 2024 (date) — Date of Report
- Cayman Islands (jurisdiction) — State of Incorporation
- Henderson, NV (location) — Principal Executive Offices
FAQ
What is the purpose of this Form 8-K filing by Zura Bio Ltd?
The Form 8-K is filed as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, and it includes a Regulation FD Disclosure and Financial Statements and Exhibits.
When was Zura Bio Ltd. previously known by another name?
Zura Bio Ltd. was formerly known as JATT Acquisition Corp, with a date of name change on April 7, 2021.
Where are Zura Bio Ltd.'s principal executive offices located?
Zura Bio Ltd.'s principal executive offices are located at 1489 W. Warm Springs Rd. #110, Henderson, NV 89014.
In which jurisdiction is Zura Bio Ltd. incorporated?
Zura Bio Ltd. is incorporated in the Cayman Islands.
What is Zura Bio Ltd.'s Standard Industrial Classification code?
Zura Bio Ltd.'s Standard Industrial Classification code is 2836, which pertains to Biological Products (No Diagnostic Substances).
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-06-06 06:03:04
Key Financial Figures
- $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
- $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma
Filing Documents
- tm2416434d1_8k.htm (8-K) — 30KB
- tm2416434d1_ex99-1.htm (EX-99.1) — 18KB
- image_002.jpg (GRAPHIC) — 3KB
- image_003.jpg (GRAPHIC) — 3KB
- image_004.jpg (GRAPHIC) — 3KB
- image_005.jpg (GRAPHIC) — 3KB
- 0001104659-24-068813.txt ( ) — 287KB
- zura-20240606.xsd (EX-101.SCH) — 3KB
- zura-20240606_def.xml (EX-101.DEF) — 26KB
- zura-20240606_lab.xml (EX-101.LAB) — 36KB
- zura-20240606_pre.xml (EX-101.PRE) — 25KB
- tm2416434d1_8k_htm.xml (XML) — 5KB
01
Item 7.01. Regulation FD Disclosure. On June 6, 2024, Zura Bio Limited issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated June 6, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 6, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer